Fresenius Kabi South Africa (PTY) LtdGroup Product Manager: IV Medicines, Standard Solutions and Oncology
Jul. 2018 - Dec. 2022Johannesburg Area, South Africa• Completed the strategic planning/vision for the product groups, each brand's Situational Analysis - Market profiles, market access analysis, key milestones and related timelines, Segmentation, Patient journeys, competitors’ analysis, and SWOT analysis. Strategy development included each product’s position statement. Tactical plans included b • Skilled in marketing research which was completed for various Gap List products, new registrations and a portfolio of chemotherapy products • Coached and managed employee reviews and training. This included coaching on brand plan development, patient journeys, data analytics, marketing research, business levers, the South African pharmaceutical industry, database development, Popi Act-, Code-, and Regulatory, compliance, Fresenius Kabi procedures, and developing their Excel skills • Content plan development which included printed and digital media marketing, researched, facilitated and approved, content creation which included HCP CPDs, advertising and marketing emails and Representative detail aids and tactics • Effectively managed KOLs, Continuous Medical Education opportunities for HCPs and conferences • Developed, arranged, and conducted field force training based on extensive self-development, research, KOL interactions, and product knowledge. Conducted strategy briefing meetings and training programs for all Representatives. • Business case development for the launching of a generic Oncology portfolio. This included an in-depth market analysis, patient journeys, data sourcing, launch plan development, and the project management of the cross-functional team to ensure the successful launch of the portfolio, budgeting, expense planning, access strategy, and pricing analysis and recommendation. Market entry strategy development and defining an ICON formulary strategy to ensure that Oncology patients have access to quality affordable medicine.